TY - JOUR T1 - Hidradenitis Suppurativa: Our Experience with a Surgical Case Management Team JO - Actas Dermo-Sifiliográficas T2 - AU - Garbayo-Salmons,P. AU - Romaní,J. AU - Ferrer de la Fuente,C. AU - Pallisera Lloveras,A. AU - López-Llunell,C. AU - Prat Escayola,J. SN - 15782190 M3 - 10.1016/j.adengl.2019.12.009 DO - 10.1016/j.adengl.2019.12.009 UR - https://actasdermo.org/en-hidradenitis-suppurativa-our-experience-with-articulo-S1578219020301372 AB - Background and objectivesThe complexity of hidradenitis suppurativa (HS) treatment calls for a multidisciplinary approach. We therefore created a multidisciplinary team to manage surgical care. This study aimed to describe the clinical characteristics of the patients we evaluated and the outcomes of the surgical techniques used. Material and methodsDescriptive cross-sectional study of 104 patients evaluated by our surgical case management team between September 2015 and July 2018. ResultsSurgery was used to treat 46% of the patients with HS who were evaluated. Most were men (73%) with no family history of HS (63%) and smokers or former smokers (76%). Gluteal HS comprised the largest phenotype group (41%) and the majority of cases were serious (Hurley stage II, 36%; stage III, 46%). The anatomical regions with the largest number of lesions were the axillae (51.9%) and the groin (41.3%). Surgery was most often performed in the axilla (38.3%), followed by the gluteus (23.4%). The most common drug treatment was a combination of rifampicin and clindamycin, Deroofing was the technique used most often (in 48% of the patients who underwent surgery). Postoperative outcomes were assessed as satisfactory overall in 63.4% of the cases. The HS lesion recurred in 20% and 12% developed wound dehiscence. ConclusionsOur experience leads us to recommend forming multidisciplinary teams to improve communication between specialists, provide tailored treatment for the patient with HS, and improve follow-up. ER -